Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the rat Matthew M. AmesDane A. MathiesenJoel M. Reid Preclinical Studies Pages: 219 - 225
Effects of benzoylphenyl ureas on growth of B16 melanoma cells in vitro and in vivo Hendricus P. HofsJ. Gordon McVie Preclinical Studies Pages: 227 - 232
Antitumor activity and mechanism of action of the marine compound girodazole François LavelleAurelio ZerialAlain Curaudeau Preclinical Studies Pages: 233 - 244
Phase I study of escalating dose mitoxantrone in combination with α-2-interferon in patients with advanced solid tumors Giampietro GaspariniSandro Dal FiorDaniel D. Von Hoff Clinical Studies Pages: 245 - 252
Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer Scott SaxmanPatrick J. Loehrer Sr.Rafat Ansari Clinical Studies Pages: 253 - 256
Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma Jaffer A. AjaniRichard PazdurIrwin H. Krakoff Clinical Studies Pages: 257 - 259
Phase II evaluation of menogaril in patients with advanced hypernephroma Harry J. Long IIIMark D. HaugeRichard G. Hahn Clinical Studies Pages: 261 - 262
Phase II trial of mitoxantrone in acute lymphocytic leukemia of childhood M. L. GrahamJ. EstradaR. W. Wilkerson Clinical Studies Pages: 263 - 267
Phase II study of echinomycin in patients with advanced breast cancer: A report of cancer and leukemia group B protocol 8641 Richard L. SchilskyDavid FaraggiI. Craig Henderson Clinical Studies Pages: 269 - 272
Phase II study of 2′-deoxycoformycin in patients with renal cell carcinoma Peter VennerElizabeth A. EisenhauerJames Johnston Clinical Studies Pages: 273 - 275
Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma Branislav JeremicLjubodrag DjuricLjiljana Mijatovic Clinical Studies Pages: 277 - 280
Clinical use of thymidine as a rescue agent from methotrexate toxicity Jean L. GremSusan A. KingMichaele C. Christian Review Article Pages: 281 - 290
